AWAKN

Portishead, United Kingdom Founded: 2020 • Age: 6 yrs Acquired By Solvonis Therapeutics
CRO focused on early stage clinical trial research
Request Access

About AWAKN

AWAKN is a company based in Portishead (United Kingdom) founded in 2020 was acquired by Solvonis Therapeutics in February 2025.. The company has 49 employees as of May 27, 2025. AWAKN has completed 2 acquisitions, including AXON Klinikken and Dr Ben Sessa. AWAKN offers products and services including AWKN-001, AWKN-002, and AWKN-SDN-14. AWAKN operates in a competitive market with competitors including ATAI, COMPASS Pathways, MindMed, Beckley Psytech and Cybin, among others.

  • Headquarter Portishead, United Kingdom
  • Employees 49 as on 27 May, 2025
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Awakn Life Sciences Uk Ltd
  • Date of Incorporation 24 Jul, 2020
  • Jurisdiction LONDON
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Healthcare → Healthcare Products & Supplies
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AWAKN

AWAKN offers a comprehensive portfolio of products and services, including AWKN-001, AWKN-002, and AWKN-SDN-14. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Medication for treating Alcohol Use Disorder.

Treatment targeting substance use disorders.

Therapeutic for mental health and addiction issues.

People of AWAKN
Headcount 10-50
Employee Profiles 1
Board Members and Advisors 10
Employee Profiles
People
David Nutt
Chief Research Officer

Unlock access to complete

Board Members and Advisors
people
Dennis Purcell
Special Advisor
people
Stephen Husbands
Advisor
people
Ann Mithoefer
Advisor
people
John Papastergiou
Independent Non-Executive Director

Unlock access to complete

Funding Insights of AWAKN

  • Total Funding
  • Total Rounds 5
  • Last Round Post-IPO — $141,045
  • First Round

    (22 Mar 2022)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2025 Amount Post-IPO - AWAKN Valuation

investors

Apr, 2024 Amount Post-IPO - AWAKN Valuation

investors

Apr, 2023 Amount Post-IPO - AWAKN Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AWAKN

AWAKN has secured backing from 1 investor. Prominent investors backing the company include Solvonis Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Novel therapeutics for addiction and mental health disorders are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AWAKN

AWAKN has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include AXON Klinikken and Dr Ben Sessa. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Standalone mental clinic
2018
Provider of psychiatric consultation services
2012
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - AWAKN

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Awakn Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AWAKN

AWAKN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ATAI, COMPASS Pathways, MindMed, Beckley Psytech and Cybin, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
domain founded_year HQ Location
Therapies for mental disorders, including psilocybin for depression, are developed.
domain founded_year HQ Location
Psychedelic-based therapies for brain health disorders are developed.
domain founded_year HQ Location
Developer of drugs for the treatment of neurological and psychiatric disorders
domain founded_year HQ Location
Psychedelic therapeutics for psychiatric disorders are developed and provided.
domain founded_year HQ Location
Psychedelic-derived therapeutics for mental illnesses are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Awakn

Frequently Asked Questions about AWAKN

When was AWAKN founded?

AWAKN was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is AWAKN located?

AWAKN is headquartered in Portishead, United Kingdom. It is registered at Portishead, England, United Kingdom.

How many employees does AWAKN have?

As of May 27, 2025, the latest employee count at AWAKN is 49.

What does AWAKN do?

AWAKN was established in 2020 and is headquartered in Portishead, United Kingdom. Operations as a contract research organization (CRO) in the life sciences sector are centered on early-stage clinical trials. Research services for drug development and clinical studies are offered, with emphasis on trial design, execution, and data management. Geographic focus remains within the UK, supporting pharmaceutical and biotech clients in regulatory-compliant research processes.

Who are the top competitors of AWAKN?

AWAKN's top competitors include MindMed, COMPASS Pathways and Beckley Psytech.

What products or services does AWAKN offer?

AWAKN offers AWKN-001, AWKN-002, and AWKN-SDN-14.

How many acquisitions has AWAKN made?

AWAKN has made 2 acquisitions, including AXON Klinikken, and Dr Ben Sessa.

Who are AWAKN's investors?

AWAKN has 1 investor. Key investors include Solvonis Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available